Global Financial Private Client’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-174
| Closed | -$84.4K | – | 1565 |
|
|
2025
Q1 | $84.4K | Buy |
174
+7
| +4% | +$3.39K | 0.03% | 280 |
|
|
2024
Q4 | $67.3K | Buy |
167
+1
| +0.6% | +$403 | 0.03% | 300 |
|
|
2024
Q3 | $77.2K | Buy |
166
+20
| +14% | +$9.3K | 0.03% | 287 |
|
|
2024
Q2 | $68.4K | Hold |
146
| – | – | 0.03% | 274 |
|
|
2024
Q1 | $61.4K | Buy |
146
+2
| +1% | +$841 | 0.03% | 287 |
|
|
2023
Q4 | $58.6K | Hold |
144
| – | – | 0.03% | 283 |
|
|
2023
Q3 | $50.1K | Hold |
144
| – | – | 0.03% | 287 |
|
|
2023
Q2 | $50.1K | Hold |
144
| – | – | 0.02% | 290 |
|
|
2023
Q1 | $45.6K | Hold |
144
| – | – | 0.02% | 290 |
|
|
2022
Q4 | $41.6K | Hold |
144
| – | – | 0.02% | 292 |
|
|
2022
Q3 | $42.8K | Hold |
144
| – | – | 0.02% | 285 |
|
|
2022
Q2 | $41.4K | Hold |
144
| – | – | 0.02% | 276 |
|
|
2022
Q1 | $38.3K | Hold |
144
| – | – | 0.02% | 292 |
|
|
2021
Q4 | $31.6K | Hold |
144
| – | – | 0.02% | 307 |
|
|
2021
Q3 | $26K | Hold |
144
| – | – | 0.01% | 290 |
|
|
2021
Q2 | $29.1K | Hold |
144
| – | – | 0.02% | 291 |
|
|
2021
Q1 | $30.7K | Hold |
144
| – | – | 0.02% | 249 |
|
|
2020
Q4 | $34K | Buy |
144
+4
| +3% | +$945 | 0.03% | 224 |
|
|
2020
Q3 | $38.3K | Hold |
140
| – | – | 0.03% | 210 |
|
|
2020
Q2 | $40.1K | Hold |
140
| – | – | 0.03% | 234 |
|
|
2020
Q1 | $31.6K | Hold |
140
| – | – | 0.03% | 260 |
|
|
2019
Q4 | $30.7K | Buy |
+140
| New | +$30.7K | 0.03% | 295 |
|